Skip to main content
Passa alla visualizzazione normale.

ANTONIO CRAXI

Publications

Date Title Type Record
2021 Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C Articolo in rivista Go to
2021 Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study Articolo in rivista Go to
2021 Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort Articolo in rivista Go to
2021 Reply to: “Hepatic benefits of HCV cure: Don't forget coagulation!” Recensione in rivista Go to
2021 Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population Articolo in rivista Go to
2021 Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b. Articolo in rivista Go to
2021 PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19 Articolo in rivista Go to
2020 Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation Articolo in rivista Go to
2020 Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease Articolo in rivista Go to
2020 Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis Articolo in rivista Go to
2020 Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease Articolo in rivista Go to
2020 Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease Articolo in rivista Go to
2020 PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD Articolo in rivista Go to
2020 Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease Articolo in rivista Go to
2020 PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease Articolo in rivista Go to
2020 Extrahepatic Manifestations of Chronic Viral C Hepatitis Review essay (rassegna critica) Go to
2020 Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study Articolo in rivista Go to
2020 Hepatic benefits of HCV cure Articolo in rivista Go to
2020 Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) Articolo in rivista Go to
2020 FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage Articolo in rivista Go to
2020 Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study Articolo in rivista Go to
2020 Optimization of hepatitis C virus screening strategies by birth cohort in Italy Articolo in rivista Go to
2020 SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study Articolo in rivista Go to
2020 Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma Articolo in rivista Go to
2019 Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group. Articolo in rivista Go to
2019 Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) Articolo in rivista Go to
2019 Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience Articolo in rivista Go to
2019 NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients Articolo in rivista Go to
2019 Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease Articolo in rivista Go to
2019 IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION Abstract in atti di convegno pubblicato in rivista Go to
2019 Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. Articolo in rivista Go to
2019 Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data Articolo in rivista Go to
2019 Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program. Articolo in rivista Go to
2019 Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience Proceedings (TIPOLOGIA NON ATTIVA) Go to
2019 Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Abstract in atti di convegno pubblicato in rivista Go to
2019 Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis Articolo in rivista Go to
2019 Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity Articolo in rivista Go to
2019 AISF position paper on HCV in immunocompromised patients Articolo in rivista Go to
2019 Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy Articolo in rivista Go to
2019 Current epidemiology of HCV in Sicily: the RESIST-HCV model Abstract in atti di convegno pubblicato in rivista Go to
2019 Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience Articolo in rivista Go to
2019 Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Articolo in rivista Go to
2019 Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients with Nonalcoholic Fatty Liver Disease Articolo in rivista Go to
2019 Update of the statements on biology and clinical impact of occult hepatitis B virus infection Articolo in rivista Go to
2018 Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study Articolo in rivista Go to
2018 Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) Nota o commento Go to
2018 Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Articolo in rivista Go to
2018 Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer? Articolo in rivista Go to
2018 Viral resistance in HCV infection. Articolo in rivista Go to
2018 Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population Articolo in rivista Go to
2018 HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals Articolo in rivista Go to
2018 L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS Proceedings (TIPOLOGIA NON ATTIVA) Go to
2018 Is global elimination of HCV realistic? Articolo in rivista Go to
2018 Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Articolo in rivista Go to
2018 Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver Articolo in rivista Go to
2018 Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis Articolo in rivista Go to
2018 Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? Articolo in rivista Go to
2018 Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. Articolo in rivista Go to
2018 Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus. Articolo in rivista Go to
2018 Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Articolo in rivista Go to
2018 Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis Articolo in rivista Go to
2018 Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study Articolo in rivista Go to
2018 Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe. Articolo in rivista Go to
2018 Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 Articolo in rivista Go to
2018 Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort Poster pubblicato in rivista Go to
2018 Real life experiences in HCV management in 2018 Articolo in rivista Go to
2018 Expert opinion on managing chronic HCV in patients with cardiovascular disease Articolo in rivista Go to
2018 Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis Articolo in rivista Go to
2018 The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance Abstract in atti di convegno pubblicato in rivista Go to
2018 Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? Lettera Go to
2018 Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Articolo in rivista Go to
2017 Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study Articolo in rivista Go to
2017 Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study Articolo in rivista Go to
2017 MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals Articolo in rivista Go to
2017 Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study Articolo in rivista Go to
2017 A focus on epidemiology of drug-induced liver injury: analysis of a prospective cohort Articolo in rivista Go to
2017 Alexithymia and personality traits of patients with inflammatory bowel disease Articolo in rivista Go to
2017 Impact of obesity, insulin resistance and hyperandrogenism on steatosis and fibrosis risk in young females with PCOS Proceedings (TIPOLOGIA NON ATTIVA) Go to
2017 Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort. Articolo in rivista Go to
2017 Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease Articolo in rivista Go to
2017 A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis Articolo in rivista Go to
2017 Hepatocellular carcinoma and direct-acting antivirals: A never ending story? Articolo in rivista Go to
2017 Primary Biliary Cholangitis: advances in management and treatment of the disease Articolo in rivista Go to
2017 Between reality and the guidelines: A survey on perception, diagnosis and management of hepatic encephalopathy in 201 Italian specialist centres Articolo in rivista Go to
2017 Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta-analysis Abstract in rivista Go to
2017 HBV recurrence after HCV clearance on DAAs: Sometimes they come back Nota o commento Go to
2017 Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens Articolo in rivista Go to
2017 Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV Articolo in rivista Go to
2017 Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter Articolo in rivista Go to
2017 Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma Articolo in rivista Go to
2017 Current and future challenges in HCV: insights from an Italian experts panel Articolo in rivista Go to
2017 Can we prevent and modify cardiometabolic disorders by controlling HCV infection? Articolo in rivista Go to
2017 Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study Articolo in rivista Go to
2017 Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study Articolo in rivista Go to
2017 Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values Articolo in rivista Go to
2017 Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD Articolo in rivista Go to
2017 Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel Articolo in rivista Go to
2017 Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease Articolo in rivista Go to
2017 Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease Articolo in rivista Go to
2017 A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma Articolo in rivista Go to
2017 Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease Articolo in rivista Go to
2017 Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity Articolo in rivista Go to
2017 Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS Articolo in rivista Go to
2017 Efficacy of a 12-week simeprevir plus peginterferon/ribavirin (PR) regimen in treatment-naïve patients with hepatitis C virus (HCV) genotype 4 (GT4) infection and mild-to-moderate fibrosis displaying early on-treatment virologic response Articolo in rivista Go to
2017 Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon Articolo in rivista Go to
2016 Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies Articolo in rivista Go to
2016 An open-label trial of 12-week simeprevir plus Peginterferon/Ribavirin (PR) in treatment-naïve patients with Hepatitis C Virus (HCV) Genotype 1 (GT1) Articolo in rivista Go to
2016 Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort Articolo in rivista Go to
2016 Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model Articolo in rivista Go to
2016 Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing Lettera Go to
2016 The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease Articolo in rivista Go to
2016 Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension Articolo in rivista Go to
2016 Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease Articolo in rivista Go to
2016 Clinical course and genetic susceptibility of primary biliary cirrhosis: Analysis of a prospective cohort Articolo in rivista Go to
2016 TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C Articolo in rivista Go to
2016 The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent Articolo in rivista Go to
2016 Renin-angiotensin system inhibitors, type 2 diabetes and fibrosis progression: An observational study in patients with nonalcoholic fatty liver disease Articolo in rivista Go to
2016 IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection Articolo in rivista Go to
2016 From current status to optimization of HCV treatment: Recommendations from an expert panel Articolo in rivista Go to
2016 Why do I treat my patients with mild hepatitis C? Articolo in rivista Go to
2016 Reply Lettera Go to
2016 Reply Lettera Go to
2016 Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening Articolo in rivista Go to
2016 Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study Recensione in rivista Go to
2016 Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population. Articolo in rivista Go to
2015 Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye. Review essay (rassegna critica) Go to
2015 Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): A randomised, double-blind, multicentre, phase 3 trial Articolo in rivista Go to
2015 Epicardial Fat, Cardiac Geometry and Cardiac Function in Patients with Nonalcoholic Fatty Liver Disease: Association with the Severity of Liver Disease Articolo in rivista Go to
2015 The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. Articolo in rivista Go to
2015 PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C Articolo in rivista Go to
2015 Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis Articolo in rivista Go to
2015 Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease Articolo in rivista Go to
2015 MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease Articolo in rivista Go to
2015 Tumor Necrosis Factor Alpha Antagonists and Occurrence of Autoantibodies in Inflammatory Bowel Disease Patients: A Single Center Experience Articolo in rivista Go to
2015 Current and future HCV therapy: Do we still need other anti-HCV drugs? Articolo in rivista Go to
2015 Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program Articolo in rivista Go to
2015 Clinical course and management of acute and chronic viral hepatitis during pregnancy. Review essay (rassegna critica) Go to
2015 Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease Articolo in rivista Go to
2015 The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity Abstract in rivista Go to
2015 The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease Articolo in rivista Go to
2015 The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients. Articolo in rivista Go to
2015 Extra-hepatic Morbidity and Mortality of Chronic Hepatitis C Articolo in rivista Go to
2015 The rs2294918 E434K variant modulates PNPLA3 expression and liver damage Articolo in rivista Go to
2015 Impact of HBV genotypes A and D genetic variability on infection evolution Articolo in rivista Go to
2015 Statin use and non-alcoholic steatohepatitis in at risk individuals Articolo in rivista Go to
2015 Epicardial fat in patients with non-alcoholic fatty liver disease Lettera Go to
2015 Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis Articolo in rivista Go to
2015 HCV: The best cure possible or the best possible cure? Nota o commento Go to
2015 Randomised clinical trial: Alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II) Articolo in rivista Go to
2015 Response to Dr. Sertoglu and colleagues Lettera Go to
2015 Refining sorafenib therapy: Lessons from clinical practice Articolo in rivista Go to
2015 Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib Articolo in rivista Go to
2015 Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy Articolo in rivista Go to
2015 The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis Articolo in rivista Go to
2014 Reply to: “Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients” Recensione in rivista Go to
2014 Clinical implications of the hyperdynamic syndrome in cirrhosis. Articolo in rivista Go to
2014 Real-world outcomes in patients with chronic hepatitis C: primary results of the PROBE study. Articolo in rivista Go to
2014 Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Articolo in rivista Go to
2014 Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin Articolo in rivista Go to
2014 health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in italy Articolo in rivista Go to
2014 EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAM Proceedings (TIPOLOGIA NON ATTIVA) Go to
2014 Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? Articolo in rivista Go to
2014 Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial Articolo in rivista Go to
2014 Reply to: Is industrial fructose just a marker of an unhealthy dietary pattern? Recensione in rivista Go to
2014 Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C Articolo in rivista Go to
2014 Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C Articolo in rivista Go to
2014 HCV-1b intra-subtype variability: Impact on genetic barrier to protease inhibitors Articolo in rivista Go to
2014 Considerations regarding the alleged association between Herbalife products and cases of hepatotoxicity: a rebuttal Articolo in rivista Go to
2014 Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C Articolo in rivista Go to
2014 The dilemma for patients with chronic hepatitis C: treat now or warehouse? Recensione in rivista Go to
2014 HCV cirrhosis at the edge of decompensation: Will ABT-450/r, ombitasvir, da- sabuvir and ribavirin solve the need for treatment? Recensione in rivista Go to
2014 CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn's disease: relationship of CT findings with CDAI and acute-phase reactants Articolo in rivista Go to
2014 Liver function test abnormalities in patients with inflammatory bowel diseases: A hospital-based survey Articolo in rivista Go to
2014 EASL Clinical Practice Guidelines: management of hepatitis C virus infection Articolo in rivista Go to
2014 Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study. Articolo in rivista Go to
2014 An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C Articolo in rivista Go to
2014 The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene Abstract in rivista Go to
2014 Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis. Articolo in rivista Go to
2013 Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients Articolo in rivista Go to
2013 Immunological alterations in hepatitis C virus infection Articolo in rivista Go to
2013 Predicting Early and Sustained Virological Responses in Prior Nonresponders to Pegylated Interferon alpha-2b Plus Ribavirin Retreated With Peginterferon alpha-2a Plus Ribavirin and The Benefit-Risk Ratio of Retreatment t Articolo in rivista Go to
2013 Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. Articolo in rivista Go to
2013 HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC Abstract in rivista Go to
2013 A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis Abstract in rivista Go to
2013 Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C Articolo in rivista Go to
2013 Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients Articolo in rivista Go to
2013 Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis. Articolo in rivista Go to
2013 Viral Sequence Analysis of Occult HBV Infection and Its Reactivation in Immunosuppressed Patients Articolo in rivista Go to
2013 How to optimize HCV therapy in genotype 1 patients: predictors of response. Articolo in rivista Go to
2013 Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference Articolo in rivista Go to
2013 Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients Proceedings (TIPOLOGIA NON ATTIVA) Go to
2013 No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. Articolo in rivista Go to
2013 Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease Articolo in rivista Go to
2013 Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial. Articolo in rivista Go to
2013 Herbal hepatotoxicity: a hidden epidemic Articolo in rivista Go to
2013 Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age? Articolo in rivista Go to
2013 Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. Articolo in rivista Go to
2013 Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study Articolo in rivista Go to
2013 High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C Articolo in rivista Go to
2013 PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease Articolo in rivista Go to
2013 Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response Abstract in rivista Go to
2013 Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Articolo in rivista Go to
2013 In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C Articolo in rivista Go to
2013 Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis Articolo in rivista Go to
2013 Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C Articolo in rivista Go to
2013 HCV genotype 5: an orphan virus Articolo in rivista Go to
2013 NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. Articolo in rivista Go to
2013 Reply to: "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients". Articolo in rivista Go to
2013 Reply. Articolo in rivista Go to
2013 Cardiovascular diseases and HCV infection: a simple association or more? Articolo in rivista Go to
2013 Osteodystrophy in chronic liver diseases Articolo in rivista Go to
2012 Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3 Articolo in rivista Go to
2012 Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia Articolo in rivista Go to
2012 Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Articolo in rivista Go to
2012 Assessment by Fibroscan of fibrosis in nonalcoholic fatty liver disease: XL versus M probe? Articolo in rivista Go to
2012 Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV Abstract in rivista Go to
2012 Preface. Hepatitis C infection. Recensione in rivista Go to
2012 Factors that predict response of patients with hepatitis C virus infection to boceprevir Articolo in rivista Go to
2012 Clinical management of drug-drug interactions in HCV therapy: Challenges and solutions. Articolo in rivista Go to
2012 "Should cirrhosis change our attitude towards treating non-hepatic cancer?" Articolo in rivista Go to
2012 Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver Articolo in rivista Go to
2012 Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C Articolo in rivista Go to
2012 Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response Articolo in rivista Go to
2012 IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. Articolo in rivista Go to
2012 Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions. Articolo in rivista Go to
2012 Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea Articolo in rivista Go to
2012 Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients. Articolo in rivista Go to
2012 Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease Articolo in rivista Go to
2012 IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Articolo in rivista Go to
2012 Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. Articolo in rivista Go to
2012 Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial Articolo in rivista Go to
2012 Chronic hepatitis C and atherosclerosis: A complex pathogenic puzzle. Articolo in rivista Go to
2012 Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. Articolo in rivista Go to
2012 Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma Articolo in rivista Go to
2012 Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. Articolo in rivista Go to
2012 herapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat? Articolo in rivista Go to
2012 Fluoroquinolone-induced liver injury: three new cases and a review of the literature. Articolo in rivista Go to
2012 Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C Articolo in rivista Go to
2012 Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study Articolo in rivista Go to
2012 Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin Articolo in rivista Go to
2012 Personality Traits, Defense Mechanisms and Perception of Quality of Life (QOL) in Patients With Inflammatory Bowel Disease (IBD) and Matched Controls Proceedings (TIPOLOGIA NON ATTIVA) Go to
2012 Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. Articolo in rivista Go to
2011 Fibrosis in chronic viral hepatitis Articolo in rivista Go to
2011 Is liver stiffness measurement unreliable in obese patients? authors' reply. Articolo in rivista Go to
2011 Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop Articolo in rivista Go to
2011 PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE Abstract in rivista Go to
2011 LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION Abstract in rivista Go to
2011 FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT Abstract in rivista Go to
2011 LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C Abstract in rivista Go to
2011 Liver follicular helper T-cells in chronic hepatitis C Abstract in rivista Go to
2011 Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Articolo in rivista Go to
2011 LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS Proceedings (TIPOLOGIA NON ATTIVA) Go to
2011 Oesophagogastroduodenoscopy in patients with cirrhosis: Extending the range of detection beyond portal hypertension Articolo in rivista Go to
2011 Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. Articolo in rivista Go to
2011 Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Articolo in rivista Go to
2011 Management of hepatitis B virus infection in the underprivileged world. Articolo in rivista Go to
2011 Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation Articolo in rivista Go to
2011 Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. Articolo in rivista Go to
2011 Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis Recensione in rivista Go to
2011 Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Articolo in rivista Go to
2011 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection Articolo in rivista Go to
2011 TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. Articolo in rivista Go to
2011 Occult hepatitis B virus infection and hepatocellular carcinoma development in patients with chronic hepatitis C Recensione in rivista Go to
2011 Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Articolo in rivista Go to
2011 High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis Articolo in rivista Go to
2011 Optimal therapy in hepatitis C virus genotypes 2 and 3 patients. Articolo in rivista Go to
2011 Hyperuricemia in non-alcoholic fatty liver disease: authors' reply. Articolo in rivista Go to
2011 Genetic predisposition to thrombophilia in inflammatory bowel disease Articolo in rivista Go to
2011 FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program Articolo in rivista Go to
2010 Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Articolo in rivista Go to
2010 Liver stiffness, a non-invasive marker of liver disease: a core study group report Articolo in rivista Go to
2010 FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT Abstract in rivista Go to
2010 PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? Abstract in rivista Go to
2010 Halitosis: could it be more than mere bad breath? Articolo in rivista Go to
2010 Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response Articolo in rivista Go to
2010 Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. Articolo in rivista Go to
2010 A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Articolo in rivista Go to
2010 Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Articolo in rivista Go to
2010 Replay Articolo in rivista Go to
2010 Reply Articolo in rivista Go to
2010 Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Articolo in rivista Go to
2010 HEPATIC STEATOSIS IS ASSOCIATED WITH SEVERE FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B Proceedings (TIPOLOGIA NON ATTIVA) Go to
2010 Does chemotherapy prevent HCV-related hepatocellular carcinoma? Cons Articolo in rivista Go to
2010 PEG IFN alfa-2a vs. alfa-2b: And the winner is ...? Articolo in rivista Go to
2010 Epidemiology, risk factors and surveillance of hepatocellular carcinoma Articolo in rivista Go to
2010 Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication. Articolo in rivista Go to
2010 INSULIN RESISTANCE, STEATOSIS AND PROGRESSION OF FIBROSIS IN PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C Proceedings (TIPOLOGIA NON ATTIVA) Go to
2010 Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial Articolo in rivista Go to
2010 Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. Articolo in rivista Go to
2010 LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C Abstract in rivista Go to
2009 Histomorphology of healthy oral mucosa in untreated celiac patients: unexpected association with spongiosis. Articolo in rivista Go to
2009 Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. Articolo in rivista Go to
2009 PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE Abstract in rivista Go to
2009 HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION Abstract in rivista Go to
2009 PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response Proceedings (TIPOLOGIA NON ATTIVA) Go to
2009 Reply Articolo in rivista Go to
2009 Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy Articolo in rivista Go to
2009 Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. Articolo in rivista Go to
2009 Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis Articolo in rivista Go to
2009 EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? Articolo in rivista Go to
2009 Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy Articolo in rivista Go to
2009 Multimodal approaches to the treatment of hepatocellular carcinoma. Articolo in rivista Go to
2009 The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report Articolo in rivista Go to
2009 PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response Proceedings (TIPOLOGIA NON ATTIVA) Go to
2009 Metastatic hepatocellular carcinoma of the parotid region without lung metastasis:a case report Articolo in rivista Go to
2009 Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. Articolo in rivista Go to
2009 Reducing treatment duration in patients infected with hepatitis C genotype 1: any need for further studies? Articolo in rivista Go to
2009 Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection Articolo in rivista Go to
2009 Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection Articolo in rivista Go to
2009 Hepatocellular Cancer: Optimal Strategies for Screening and Surveillance Articolo in rivista Go to
2009 Re-treatment of Patients With Chronic Hepatitis C Who Do Not Respond to Peginterferon-[alpha]2b: A Randomized Trial Articolo in rivista Go to
2009 HEPATITIS C AND DIABETES: THE INEVITABLE COINCIDENCE? Articolo in rivista Go to
2009 Chronic hepatitis B: who to treat and which choice of treatment? Articolo in rivista Go to
2009 OptimizingthetreatmentofchronichepatitisduetohepatitisCvirus genotypes 2 and 3: a review Articolo in rivista Go to
2009 Hyperferritinemia is a risk factor for steatosis in chronic liver disease. Articolo in rivista Go to
2009 Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. Articolo in rivista Go to
2009 HCV genotypes in Sicily: is there any evidence of a shift? Articolo in rivista Go to
2009 Oral dysphagia. An unique symptom for a wide spectrum of diseases Articolo in rivista Go to
2009 Non-alcoholic fatty liver disease pathogenesis: The present and the future Articolo in rivista Go to
2009 Implication of Normal Liver Enzymes in Liver Disease Articolo in rivista Go to
2009 Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Articolo in rivista Go to
2009 Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. Articolo in rivista Go to
2009 Reply Articolo in rivista Go to
2009 Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis Articolo in rivista Go to
2008 Coeliac disease: Oral ulcer prevalence, assessment of risk and association with gluten-free diet in children. Articolo in rivista Go to
2008 Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome Proceedings (TIPOLOGIA NON ATTIVA) Go to
2008 Hepatitis C virus (HCV) infection: a systemic disease. Articolo in rivista Go to
2008 Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis Articolo in rivista Go to
2008 Statements from the Taormina expert meeting on occult hepatitis B virus infection. Articolo in rivista Go to
2008 Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Articolo in rivista Go to
2008 Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. Articolo in rivista Go to
2008 HCV genotypes in western Sicily: any evidence for a shift? Proceedings (TIPOLOGIA NON ATTIVA) Go to
2008 Inguinal hernioplasty improves the quality of life in patients with cirrhosis. Articolo in rivista Go to
2008 Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. Articolo in rivista Go to
2008 CLINICAL COURSE OF NIMESULIDE-INDUCED LIVER INJURY Proceedings (TIPOLOGIA NON ATTIVA) Go to
2008 Introduction. Necroinflammation and the course of chronic hepatitis. Articolo in rivista Go to
2008 Phylogenetic Reconstruction of HCV Genotype 1b Dissemination in a Small City Centre: The Camporeale Model Articolo in rivista Go to
2008 Reply Articolo in rivista Go to
2008 Extrahepatic manifestations of hepatitis C virus infection. Articolo in rivista Go to
2008 Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C Articolo in rivista Go to
2008 Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay Articolo in rivista Go to
2008 Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Articolo in rivista Go to
2008 751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS Articolo in rivista Go to
2008 Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. Articolo in rivista Go to
2008 Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems Articolo in rivista Go to
2007 Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the 'accordion' regimen? Articolo in rivista Go to
2007 Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial Articolo in rivista Go to
2007 The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Articolo in rivista Go to
2007 STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD Proceedings (TIPOLOGIA NON ATTIVA) Go to
2007 INSULIN RESISTANCE AND SEVERITY OF FIBROSIS IN HCV GENOTYPE 1 CHRONIC HEPATITIS. Proceedings (TIPOLOGIA NON ATTIVA) Go to
2007 Seeding after radiofrequency thermal ablation of hepatocellular carcinoma in cirrhosis: a prospective study Proceedings (TIPOLOGIA NON ATTIVA) Go to
2007 Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier Proceedings (TIPOLOGIA NON ATTIVA) Go to
2007 Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner Proceedings (TIPOLOGIA NON ATTIVA) Go to
2007 Adefovir for lamivudine resistant HBV: More than meets the eye. Articolo in rivista Go to
2007 Oral Mucosa of celiac disease patients produces anti-endomysial and anti-transglutaminase antibodes. Diagnostic usefulness of an in vitro culture system Articolo in rivista Go to
2007 Oral pathology in untreated coeliac disease Articolo in rivista Go to
2007 The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study Proceedings (TIPOLOGIA NON ATTIVA) Go to
2006 Histomorphological features of healthy oral mucosa in coeliac patients: unexpected association with spongiosis”. Proceedings (TIPOLOGIA NON ATTIVA) Go to
2006 Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. Articolo in rivista Go to
2006 Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6,999 cases Articolo in rivista Go to
2006 Modulation of epitope-specific anti-hepatitis C virus E2(anti-HCV/E2)antibodies by anti-viral treatment Articolo in rivista Go to
2006 From viral pathobiology to the treatment of hepatitis B virus infection EASL Monothematic Conference (Istanbul, Turkey, October 6-8, 2005). Articolo in rivista Go to
2006 Reversibility of fibrosis Capitolo o Saggio Go to
2006 Treating patients with HCV genotype 1 and low viraemia: more than meets the eye Articolo in rivista Go to
2006 Histomorphological features of health oral mucosa in celiac patients:unexspected association with spongiosis. Proceedings (TIPOLOGIA NON ATTIVA) Go to
2006 Halitosis and HCV-related liver disease:true association Proceedings (TIPOLOGIA NON ATTIVA) Go to
2006 Acute hepatitis C: in search of the optimal approach to cure. Articolo in rivista Go to
2006 Chemoprevention of hepatocellular carcinoma. Capitolo o Saggio Go to
2006 Epatite cronica C: l'ottimizzazione della terapia. Monografia Go to
2006 GRAVE EMORRAGIA RICORRENTE DEL CONDOTTO ILEALE DA IPERTENSIONE PORTALE: PRIMA ESPERIENZA MONDIALE CON SCLEROTIZZAZIONE VASALE ECOGUIDATA Articolo in rivista Go to
2006 Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C Articolo in rivista Go to
2006 Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial Articolo in rivista Go to
2006 Treatment options in HBV. Articolo in rivista Go to
2005 Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b Articolo in rivista Go to
2005 HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy Articolo in rivista Go to
2005 Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin Articolo in rivista Go to
2005 Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life Articolo in rivista Go to
2005 Valutazione della clearance di HCV-RNA sotto trattamentio antivirale con Transcription-Mediated Amplification (TMA) Proceedings (TIPOLOGIA NON ATTIVA) Go to
2005 Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study Articolo in rivista Go to
2005 Infezione occulta da HBV in pazienti con malattie oncoematologiche Proceedings (TIPOLOGIA NON ATTIVA) Go to
2005 Epidemiologia molecolare dell'infezione da HCV in un Comune Siciliano Proceedings (TIPOLOGIA NON ATTIVA) Go to
2005 Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center Articolo in rivista Go to
2005 GRAVE EMORRAGIA RICORRENTE DEL CONDOTTO ILEALE DA IPERTENSIONE PORTALE . PRIMA ESPERIENZA MONDIALE CON SCLEROTIZZAZIONE ECOGUIDATA Capitolo o Saggio Go to
2005 Hepatitis B virus reactivation and alemtuzumab therapy Articolo in rivista Go to
2005 Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) Proceedings (TIPOLOGIA NON ATTIVA) Go to
2005 GRAVE EMORRAGIA RICORRENTE DEL CONDOTTO ILEALE DA IPERTENSIONE PORTALE: PRIMA ESPERIENZA MONDIALE CON SCLEROTIZZAZIONE VASALE ECOGUIDATA. Proceedings (TIPOLOGIA NON ATTIVA) Go to
2005 Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms Articolo in rivista Go to
2005 La malattia epatica da epatite C: una condizione guaribile? Articolo in rivista Go to
2005 Treatment of hepatitis C: critical appraisal of the evidence Articolo in rivista Go to
2005 Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir Proceedings (TIPOLOGIA NON ATTIVA) Go to
2005 Response to letter from Professor Peter Ferenci Articolo in rivista Go to
2005 RUOLO DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO Proceedings (TIPOLOGIA NON ATTIVA) Go to
2005 Prevention of hepatocellular carcinoma Articolo in rivista Go to
2004 Oxidative stress inhibits expression of alfa-IFN induced antiviral genes by suppressing tyrosine phosphorylation of Stat-1 in huh 7 cells Proceedings (TIPOLOGIA NON ATTIVA) Go to
2004 The aetiology of chronic hepatitis in Italy: results from a multicentre national study Articolo in rivista Go to
2004 Hepatitis B virus reactivation and alemtuzumab therapy Proceedings (TIPOLOGIA NON ATTIVA) Go to
2004 Early virologic response with pegylated interferons Articolo in rivista Go to
2004 Characteristics of liver cirrhosis in Italy: results from a multicenter national study Articolo in rivista Go to
2004 Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial Articolo in rivista Go to
2004 HCV infection and oral lichen planus: a weak association when HCV is endemic Articolo in rivista Go to
2004 Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data Articolo in rivista Go to
2004 The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards Articolo in rivista Go to
2004 Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection Articolo in rivista Go to
2004 HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin Articolo in rivista Go to
2004 Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C Articolo in rivista Go to
2004 Percutaneous radiofrequency therma ablation of small hepatocellular carcinoma: a prospective study Proceedings (TIPOLOGIA NON ATTIVA) Go to
2004 Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine Articolo in rivista Go to
2004 The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach Articolo in rivista Go to
2004 A woman with a long history of abdominal pain Articolo in rivista Go to
2004 Interferon therapy: the other face of the medal. Ann Ital Med Int. 2004;19(1):5-7. Articolo in rivista Go to
2004 Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis Articolo in rivista Go to
2004 Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity Articolo in rivista Go to
2004 UNRESECTABLE HEPATOCELLULAR CARCINOMA:META-ANALYSIS OD ARTERIAL EMBOLIZATION Articolo in rivista Go to
2004 Emocromatosi Articolo in rivista Go to
2004 The aetiological pattern of hepatocellular carcinoma ( HCC) in Italy is changing Abstract in rivista Go to
2004 Patologie da sovraccarico di ferro:recenti acquisizioni Articolo in rivista Go to
2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C Articolo in rivista Go to
2003 Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C Articolo in rivista Go to
2003 ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin Articolo in rivista Go to
2003 Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV Articolo in rivista Go to
2003 When and how to treat acute hepatitis C? Articolo in rivista Go to
2003 Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract Articolo in rivista Go to
2003 Clinical trial results of peginterferons in combination with ribavirin Abstract in rivista Go to
2003 IL-10 and TNF-α polymorphisms and the recovery from HCV infection Articolo in rivista Go to
2003 A patient with acute hepatitis C and possible IFN toxicity [2] Articolo in rivista Go to
2002 Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction Articolo in rivista Go to
2002 Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission Articolo in rivista Go to
2002 Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis Articolo in rivista Go to
1979 ATTUALI ORIENTAMENTI NELLA DIAGNOSTICA DELLA MALATTIA DI HIRSCHSPRUNG Articolo in rivista Go to